CRISPR THERAPEUTICS AG COM CHF0.03 earnings per share and revenue

0VRQ earnings per share for the last quarter are -1.01 USD whereas the estimation was -1.41 USD which accounts for 28.29% surprise. Company revenue for the same period amounts to 602.00 k USD despite the estimated figure of 6.54 M USD. Estimated earnings per share for the next quarter are -1.19 USD, and revenue is expected to reach 7.85 M USD. Also watch annual changes over time to get a bigger picture of 0VRQ earnings per share and revenue dynamics.